Unibest

Pharmaceutical intermediates

Tegoprazan Intermediates

3 pharmaceutical intermediates for Tegoprazan. Indication: Gastroesophageal reflux disease; Helicobacter pylori infection; Duodenal ulcer.

提交项目All intermediates

About Tegoprazan

Originator
Pfizer Inc
Indication
Gastroesophageal reflux disease; Helicobacter pylori infection; Duodenal ulcer
Approved Date
04/08/2022

Available intermediates

3 intermediates currently listed for Tegoprazan. Request specifications, documentation or a quotation for any item below.

Tegoprazan intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(R)-5,7-difluorochroman-4-ol1270294-05-7//
1-benzyl-4-hydroxy-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid1640981-19-6//
7-hydroxy-N,N,2-triMethyl-3-tosyl-3H-benzo[d]iMidazole-5-carboxaMide942195-86-0//

Other programs under T

Tazemetostat HydrobromideTazobactam SodiumTenapanor HydrochlorideTeneligliptinTetrabenazineTezacaftorTianeptine sodium saltTicagrelor

Building toward Tegoprazan?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →